Distal Transradial Access European ThinkRadial

Merit Medical at AACN National Teaching Institute (NTI) and Critical Care Expo 2019

Distal Transradial Access European ThinkRadial

Most Interventional Cardiologists throughout Europe support a radial-first approach for PCI. And more and more Interventional Radiologists and Neuro Radiologists admit that radial access plays a prominent role in an operator’s practice.

Merit Medical’s ThinkRadialTM program brings together these disciplines with one goal: leverage the benefits of using transradial access (TRA) in reduction of access-site complications and bleeding.1,2 In addition, a shorter hospital stay for the patient and therefore lower costs in most cases.3 Patient preference also plays a role: patients tend to prefer access via the wrist as opposed to their groin, and experience faster recovery.4

To enable physicians to benefit from TRA-practices, Dr. Ferdinand Kiemeneij (Interventional Cardiologist, The Netherlands) and Dr. Darren Klass (Interventional Radiologist, Canada) hosted another ThinkRadial program on June 28 and 29th in Maastricht, Netherlands. Dr. Ferdinand Kiemeneij, honoured at the 2018 EuroPCR meeting as one of the pioneers of the transradial approach for coronary catheterization and intervention (TRI), presented to the participants the left distal radial approach.

Physicians from 11 countries joined the programme to experience an effective combination of research-based learning and practical ‘tips and tricks’. After a mix of theory and practicing TRA procedures in simulation lab sessions and with cadavers, all participants left with the knowledge and skills needed to develop their own TRA practice in their hospital.

Distal Transradial Access European ThinkRadial
Distal Transradial Access European ThinkRadial

Interested in joining the ThinkRadial Community?

Merit Medical organizes ThinkRadial courses across the world. Please check here for the next course date. Looking forward to meeting you there!

Nigel Warren
Vice-President Peripheral Intervention EMEA


References

  1. Jolly, S. S., Yusef, S., Cairns, J., et al. (2011). Radial versus femoral access for coronary angiography and intervention for patients with acute coronary syndromes (RIVAL): A randomised, parallel group, multicentre trial. Lancet, Apr 23;377(9775):1409-1420.
  2. Valgimigli, M., Gagnor, A., Calabró, P., et al. (2015). Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: A randomised multicentre trial. Lancet, Jun 20;385(9986):2465-2476.
  3. Shroff, A. (Sept/Oct 2011). Economic opportunities of transradial angiography and intervention. Retrieved from https://citoday.com/2011/10/economic-opportunities-of-transradial-angiography-and-intervention
  4. Fischman, A. M., Swinburne, N. C., & Patel, R. S. (2015). A technical guide describing the use of transradial ac cess technique for endovascular interventions. Tech Vasc Interv Radiol, Jun;18(2):58-65.

Merit Medical Offers Full Range of Manual Bone Biopsy System Devices

Brighton Bipolar Probe®

The Brighton Bipolar Coagulation Probe is intended to be passed through an endoscope’s working channel to provide hemostasis throughout the gastrointestinal tract.


Advantages

  • Silver spiral electrode pair design provides constant power and thermal conductivity.
  • Hydrophilic coated tip can reduce probe adherence for more effective coagulation.
  • Round distal tip helps promote precise burn from various angles.
  • Unique catheter material facilitates passage through the endoscope and virtually eliminates kinking while providing optimum tamponade.
  • 350cm length offers one size to fit most endoscopes.
  • Dual and single plugs to fit most bipolar generators.
  • Irrigation through central lumen to effectively remove debris.
  • Purple color enhances positive endoscopic identification of the tip and catheter transition.
Brighton Bipolar Probe

Ordering Information

Catalog NumberDescriptionLengthGenerator Plug Type
BP-10F-DP-35010F (3.3mm)350cmDual
BP-10F-SP-35010F (3.3mm)350cmSingle
BP-7F-DP-3507F (2.3mm)350cmDual
BP-7F-SP-3507F (2.3mm)350cmSingle

Documents

Brighton Bipolar Probe Brochure®


Brighton Bipolar Coagulation Probe Instructions for Use (English)


Brighton Bipolar Coagulation Probe Instructions for Use (Multilingual)

WCIO

Merit Medical to Attend World Conference of Interventional Oncology 2017

Merit Medical is pleased to attend the Western Conference of Interventional Oncology (WCIO) in Boston from June 8-10.

WCIO will be conducting several workshops where you can view Merit products.

Friday, June 9 | 9:15-10:45am | MSK & Spine Interventions Saturday, June 10 | 9:15-10:45am | Ablative Therapies Saturday, June 10 | 1:30-3:00pm | Hepatic Intra-Arterial Therapies

To visit our booth, please stop by #510.

HeRO Graft - Hemodialysis Reliable Outflow

HeRO™ Graft Bypasses Central Venous Stenosis, Improves Hemodialysis

HeRO Graft - Hemodialysis Reliable Outflow

Central venous stenosis is a common and serious vascular complication among long-term hemodialysis patients that can lead to the loss of vascular access and a diminished life expectancy. To bypass venous stenosis and improve long-term hemodialysis adequacy, various permanent subcutaneous arteriovenous graft devices have been manufactured as a solution for hemodialysis patients who have exhausted all other access options.

One such product called the HeRO™ Graft was approved by the FDA in 2008. In comparison to catheters, it’s the only clinically proven permanent subcutaneous arteriovenous graft to reduce the risk of vascular access-related infections by 69%, improve adequacy of hemodialysis by up to 32% (1.7 Kt/V), and cut interventions needed to maintain access function by more than half.1 Studies have also linked the HeRO Graft to high cumulative patency rates that reach 87% at two years.2

Cost savings advantages have also been linked with using the HeRO Graft. A US healthcare model for provision of hemodialysis access predicted that in comparison to catheters, using the HeRO Graft could result in an average of 23% annual savings.3 Dialysis centers could save over $3000 per patient each year.4 And hospitals can save thousands in hefty admission costs that accrue because of device-related infections—rates that would commonly range between $23K to $56K per stay.5,6

What makes the HeRO Graft so unique?

Unlike other graft products, the HeRO Graft doesn’t depend on venous anastomosis to bypass venous stenosis. Instead, a radiopaque silicone Venous Outflow component reinforced with kink and crush-resistant nitinol braid is placed in the right atrium and securely attaches to an adjacent ePTFE hemodialysis graft by way of a proprietary titanium connector. This mechanism allows for blood to return from the arteries back to the heart.

To learn more about the HeRO Graft and how you can apply it to your practice, sign up for the upcoming Think HeRO training course held on March 30-31 at the Houston Methodist Institute for Technology, Innovation & Education (MITIESM) in Houston, Texas, by talking to your Merit representative or visiting Merit.com/Education

  1. Katzman, H., McLafferty, R., Ross, J., Glickman, M., Peden, E., & Lawson, J. (2009). Initial experience and outcome of a new hemodialysis access device for catheter-dependent patients. J Vasc Surg, 50(3): 600-607.e1.
  2. Gage, S., Katzman, H., Ross, J., Hohmann, S., Sharpe, C., Butterly, D., & Lawson, J. (2012). Multi-center experience of 164 consecutive Hemodialysis Reliable Outflow [HeRO] Graft implants for hemodialysis treatment. Eur J Vasc Endovasc Surg, 44(1): 93-99.
  3. Dageforde, L., Bream, P., & Moore, D. (2012). Hemodialysis Reliable Outflow (HeRO) device in end-stage dialysis access: a decision analysis model. J Surg Res, 177(1): 165-171.
  4. Yost, L., Dinwiddie, L. (2010, Nov.). Impact of the use of the HeRO vascular access graft vs. tunneled dialysis catheters on dialysis provider economics in an era of bundling. Poster session presented at ASN, American Society of Nephrology, Denver, CO.
  5. Ramanathan, V., Chiu, E., Thomas, J., Khan, A., Dolson, G., & Darouiche, R. (2007). Healthcare costs associated with hemodialysis catheter–related infections: a single‐center experience. Infect Control Hosp Epidemiol, 28(5): 606-609.
  6. O’Grady, N., Dellinger, E., Gerberding, J., Heartd, S. Maki, D., Masur, H., McCormick, R., Mermel, L., Pearson, M., Raad, I., Randolph, A., & Weinstein, R. (2002). Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Center for Disease Control and Prevention, U.S. Pediatrics, 110(5): e51.
Merit Medical - American Heart Month 2020 - Merit is a Heart Company

American Heart Month at Merit